Who are Hypercell Technologies's investors?

Hypercell Technologies's investors include Serra Ventures, SOSV.

How much funding has Hypercell Technologies raised?

Hypercell Technologies has disclosed $1.1M raised across 1 round.

Where is Hypercell Technologies headquartered?

Hypercell Technologies is headquartered in Brookhaven, US.

Hypercell Technologies

Brookhaven, US · Founded 2021 · Delaware corporation · 2 known investors

Find your way into Hypercell Technologies

Paths you didn't know you had: your email and LinkedIn already hold routes to the Hypercell Technologies team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.

Biotech FoodTech Healthtech Medical Devices

Founders & leadership

Brian McFarlane Chief Commercial OfficerBrian McFarlane has over 25 years of experience in food safety and protein production systems, having worked on supply chain optimization and technology commercialization for major food companies in the beef and pork sectors. He holds an affiliate staff position at Colorado State University and serves as Chief Commercial Officer at Hypercell Technologies.

Loïc Deblais Chief Science OfficerLoïc Deblais has held lab management and R&D scientist roles in microbiology and molecular biology, with experience in bioprocess optimization, quality assurance, and technology transfer in the agriculture and pharmaceutical sectors. He holds 3 patents and has authored multiple publications in his field.

Sam JactelMember Board of DirectorsCo-Founder & COO, Hypercell Technologies

Bruno JactelCo-Founder and CEO2020–2025CEO & Co-Founder, Hypercell Technologies

Investors · 2

Serra Ventureslisted by Serra VenturesChampaign · $5M

How we know: Serra Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

SOSVlisted by SOSVNew York · $30K – $550K

How we know: open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 1 round · 2021

▶$1.1MraisedSep 2021 · 6 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Sam JactelExecutive Officer, Director
Bruno JactelExecutive Officer, Director

Offering amount: $1.8M
Amount sold: $1.1M
Minimum investment: $1
First sale: Aug 2021
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Hypercell Technologies do?: Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.
Who are Hypercell Technologies's investors?: Hypercell Technologies's investors include Serra Ventures, SOSV.
How much funding has Hypercell Technologies raised?: Hypercell Technologies has disclosed $1.1M raised across 1 round.
Where is Hypercell Technologies headquartered?: Hypercell Technologies is headquartered in Brookhaven, US.